Wolverine Asset Management LLC Exelixis, Inc. Put Options Transaction History

Wolverine Asset Management LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2018 Feb 14, 2019	SELL	$13.65 - $21.8 $1.23 Million - $1.96 Million	-89,800 Reduced 99.78%	200 $3,000
Q4 2017 Feb 14, 2018	SELL	$24.23 - $30.93 $208,378 - $265,998	-8,600 Reduced 8.72%	90,000 $2.74 Million
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $200,810 - $251,464	8,600 Added 9.56%	98,600 $2.39 Million
Q2 2017 Aug 14, 2017	BUY	N/A	90,000	90,000 $2.22 Million

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.